| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ddc142ff7e240eda9059f11aad2723f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d01d82877e7de5d4c2c522382e98f0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cef91d05dc0c7cde1082c1009c6500f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3481ed1f19fadaad1c3381f53f944a07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3560a3438d427259ab4711e70f32e3f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91bd7e31102d9694493b31c70467c2c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6468366f27a2f0da4dfadadf11c60123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b80b969113949201d00d0135601ebc3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72fddc532d4be5ef37d52a6e64a0abcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a422d9e12891ac0ec4eb858287fe4da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 |
| filingDate |
2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31420701c43dde21d6e2b86fa77c2d09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a3b7eac46c788f4b03239c91e19610d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3be7a3efb11e428ec1c8392c709ab64c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287f902eec3a5177898ba1852b660daa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_771d816335e74097c64a288231b92a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a34ce3bc261a1af3b5f83460197ffadf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eca42826410c1f2694650090656859c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8ebce0894565a22615150404461ed8 |
| publicationDate |
2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9206209-B2 |
| titleOfInvention |
Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition |
| abstract |
An exemplary emboidment is related to a pharmaceutical composition of the class of nucleotide analogues and antiviral pro-nucleotides useful in partial or complete inhibition of human immunodeficiency virus (HIV). An exemplary embodiment is expressed in the formula (XVI): n nwhere X stands for N 3 and B stands for thymidine-1-yl, or X stands for H and B stands for uracil-1-yl or adenin-1-yl or hypoxanthin-1-yl.A method of synthesis of the nucleotide analogue using a phosphorylating agent for synthesis of the nucleotide analogue is provided. |
| priorityDate |
2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |